A detailed history of New Leaf Venture Partners, L.L.C. transactions in Passage Bio, Inc. stock. As of the latest transaction made, New Leaf Venture Partners, L.L.C. holds 2,497,922 shares of PASG stock, worth $1.57 Million. This represents 2.4% of its overall portfolio holdings.

Number of Shares
2,497,922
Previous 2,497,922 -0.0%
Holding current value
$1.57 Million
Previous $3.37 Million 41.49%
% of portfolio
2.4%
Previous 2.96%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

BUY
$8.86 - $22.2 $22.1 Million - $55.5 Million
2,497,922 New
2,497,922 $39.3 Million

Others Institutions Holding PASG

About Passage BIO, Inc.


  • Ticker PASG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,463,200
  • Market Cap $34.3M
  • Description
  • Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...
More about PASG
Track This Portfolio

Track New Leaf Venture Partners, L.L.C. Portfolio

Follow New Leaf Venture Partners, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Leaf Venture Partners, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on New Leaf Venture Partners, L.L.C. with notifications on news.